By Drug Target Review2025-03-06T09:00:10
Scaling up cell therapy is no easy feat. PluriCDMO's Andy Lewin reveals the critical factors for success and how they are helping companies bring life-saving therapies to market.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2023-01-04T16:08:55
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-05-10T11:18:16
Sponsored by Revvity
2023-03-08T16:29:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud